Grand View Research’s surgical robots industry data book is a collection of market sizing information & forecasts, trade data, pricing intelligence, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, such information is systematically analyzed and provided in the form of outlook reports and summary presentations on individual areas of research along with a surgical robots statistics e-book.
Areas of Research
Number of Reports/Presentations in the Bundle
Cumulative Coverage of Countries
Highlights of Datasets
Total Number of Tables (Excel) in the Bundle
Total Number of Figures in the Bundle
Surgical Robots Industry
USD 3.5 billion in 2022
18.0% CAGR (2023-2030)
Orthopedics Market Size
USD 0.81 billion in 2022
12.8% CAGR (2023-2030)
Non-Orthopedics Market Size
USD 2.74 billion in 2022
19.2% CAGR (2023-2030)
The global surgical robots market was valued at USD 3.5 Billion in 2022 and is anticipated to grow at a CAGR of 18.0 % over the forecast period. The market growth is attributed to the rising adoption of automated equipment used for surgical procedures coupled with the increasing shortage of surgeons and physicians. COVID-19 has further impacted the market by increasing awareness regarding the benefits, such as the reduced risk of contamination and human error, associated with the adoption of surgical robots. Moreover, increasing investment by international and regional players in the technological advancements of surgical robots is anticipated to drive the market's growth over the forecast period.
North America held the largest market share in 2022, owing to the presence of technologically advanced healthcare infrastructure coupled with the increasing adoption of automated surgical equipment. Furthermore, the increasing prevalence of chronic disorders such as diabetes, cardiovascular disease, and cancer is anticipated to drive the demand for advanced and cost-effective surgical robots in the region. According to an article published by Johns Hopkins University, robotic cardiac surgery is a minimally invasive heart surgery performed with robot-controlled tools and instruments. The procedure is generally called Da Vinci surgery based on the name of the manufacturer of the robot.
The Asia Pacific region is anticipated to show the fastest CAGR of 18.4% over the forecast period. The growth is attributed to the increasing government support in the form of initiatives and findings for the development of healthcare infrastructure coupled with the growing geriatric population. According to APAC News Network, in 2023, India had 66 robotic surgical centers, and around 12,800 robotic surgeries were conducted over the past 12 years.
The global orthopedics market was valued at USD 805.7 million in 2022 and is anticipated to grow at a CAGR of 12.8% over the forecast period. The growth is attributed to the increasing prevalence of orthopedic conditions, such as degenerative bone disease, the growing geriatric population, and an increasing number of accidents. According to a study conducted by WHO, around 80% of the geriatric population lives in middle and low-income nations. This is anticipated to create a huge opportunity for key players in the market to expand their presence in emerging nations.
Moreover, the early onset of musculoskeletal problems, mostly caused by a sedentary lifestyle and obesity, is expected to drive market expansion. Musculoskeletal diseases affect around 1.71 billion people globally, according to the Global Burden of Disease in 2021. As a result, an increase in musculoskeletal problems is expected to drive the market over the forecast period. Additionally, growing awareness regarding the availability of innovative items is causing hospitals to improve their technology and services frequently. Furthermore, payment coverage for orthopedic therapies has contributed to the adoption of orthopedic procedures.
Prominent players in the market are adopting strategies such as acquisitions, collaborations, new product launches, and expansions to strengthen their market position. For instance, in May 2023, Zimmer Biomet Holdings, Inc. announced the acquisition of OSSIS, a medical company specializing in customized 3D-printed implants and complex hip replacements. This acquisition is expected to enhance Zimmer Biomet’s capabilities in providing technologically advanced personalized orthopedic solutions.
Non-Orthopedic applications of surgical robots include robots for neurology, cardiology, gynecology, urology, and others. The global non-orthopedic market was valued at USD 2.74 billion in 2022 and is anticipated to grow at a CAGR of 19.2% over the forecast period. The growth is attributed to the increasing prevalence of neurological disorders coupled with the rising number of road accidents causing brain injuries. According to the International Brain Injury Association, around one million traumatic brain injuries are treated in the United States every year. Additionally, around 80,000 patients are discharged from hospitals with traumatic brain injury disability.
Furthermore, technological advancements in the field of neurology, urology, and gynecology have eliminated direct human involvement in surgical operations. These devices are reducing the downsides of invasive procedures. Data recorders, HD microscopic cameras, remote navigation systems, motion sensors, transducers, and robotic-controlled catheters are among the most recent advancements. The major market participants are investing much in R&D to develop technologically advanced medical devices. For example, Brain Scientific, Inc. will deliver the next-generation NeuroCap device in March 2021. It is an advanced EEG electrode array that is utilized in clinical and research settings to deliver quick EEGs whenever required. This is anticipated to drive market growth in the coming years.
Furthermore, the increasing prevalence of high blood pressure and diabetes is also contributing to the rising demand for efficient and technologically advanced urology solutions. According to data published by the American Kidney Fund, around 25% of kidney failures are caused due to high blood pressure, and around 38.4% of kidney conditions are caused due to diabetes. The aforementioned factor is anticipated to drive the market demand over the forecast period.
Moreover, key players in the market are acquiring new players in the market to strengthen their market share and expand to untapped markets. In addition, market players are investing in R&D for the development of technologically advanced solutions. In September 2021, NovaSignal Corp. announced the closing of a USD 31 million Series C1 funding round. The company will use the resources for its commercial expansion, and development of innovative products.
Increasing demand for surgical robots is increasing competition in the market and, thus, forcing key players to introduce new products of different capabilities in the market. Additionally, it is projected that rising industry consolidation activities, such as acquisitions and mergers by the leading market participants, as well as increasing efforts in R&D of surgical robot applications by key players, are also expected to boost the market share. For instance, in May 2023, Medtronic Private Limited, a subsidiary of Medtronic plc, announced a partnership with AIIMS New Delhi to open a state-of-the-art surgical robot training center at AIIMS. This partnership is expected to provide training to surgeons regarding robotic-assisted surgery. This strategic initiative is anticipated to increase the awareness of Medtronic’s Hudo robotic-assisted surgery system among surgeons.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
"The quality of research they have done for us has been excellent..."